Skip to main content

Bank of New York Mellon Corp

Bank

Position in LGND — Ligand Pharmaceuticals Inc

CIK 1390777 NEW YORK, NY

Position in LGND

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$23,838,803
+$722,165 QoQ
Shares Held
119,403
-2.3% QoQ
Ownership
0.596%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 90.26992621625922.ToString("F0")% Shared 0.ToString("F0")% None 9.730073783740776.ToString("F0")%

Common Shares in LGND Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Bank of New York Mellon Corp holds $4,203,063,863 across 270 Biotechnology names. LGND ranks #30 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LGND

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $23,838,803 119,403
2025-12-31 $23,116,638 122,265
2025-09-30 $22,585,170 127,499
2025-06-30 $14,563,086 128,106
2025-03-31 $13,307,671 126,571
2024-12-31 $13,928,640 129,992
2024-09-30 $13,496,032 134,839
2024-06-30 $12,301,115 145,990
2024-03-31 $10,757,685 147,164
2023-12-31 $11,110,019 155,559
2023-09-30 $8,731,958 145,727
2023-06-30 $10,949,754 151,869
2023-03-31 $11,116,457 151,121
2022-12-31 $10,476,441 156,833
2022-09-30 $8,731,587 162,545
2022-06-30 $9,164,770 164,662
2022-03-31 $12,916,913 184,068
2021-12-31 $18,468,221 191,665
2021-09-30 $16,392,815 188,614
2021-06-30 $15,547,687 189,976
2021-03-31 $17,173,676 180,580
2020-09-30 $12,407,112 208,651
2020-06-30 $15,522,508 222,464
2020-03-31 $10,605,856 233,790